About us
Vectalys platform
Flash Therapeutics
News
Newsletter
Distributor
Who to contact?
Lentiviral
Based Technologies
Our Know-How
Lentiviral vectors
LentiFlash® particles
Cell line development
Our
Lentiviral Platform
For research project
For pre-clinical studies
For clinical studies
Applications
of Lentiviral Technologies
Gene editing - KO
Gene editing - KI
Immunotherapy
About us
Vectalys platform
Flash Therapeutics
News
Newsletter
Distributor
Who to contact?
Home
Stay informed about our latest innovations
Subscribe to the newsletter
Name
Email*
Company/Institute
Topic of interest
In accordance with the French Data Protection and Freedom of Information Law (Loi Informatique et Liberté) of 6 January 1978, You have the right to access, modify, rectify and delete any data concerning you. Contact us for more informations.
Looking for an efficient CRISPR delivery system ?
06-07-2017
LentiFlash™ particles carrying CRISPR-Cas9 technology show promising results to disrupt targeted genes in several therapeutic fields!
Want to target gene expression in specific cells or tissues ?
20-06-2017
Try pre-made lentiviral particles carrying reporter genes driven by tissue-specific promoters for both in vitro and in vivo applications.
Posters AACR 2017
04-05-2017
RNA delivery into primary T cells for both gene editing & immunotherapy applications.
1
2
3
4
5
6